Related Experiment Videos
Molecular interactions required for triggering alloantigen-specific cytolytic T lymphocytes.
K P Kane1, L A Sherman, M F Mescher
1Division of Membrane Biology, Medical Biology Institute, La Jolla, CA 92037.
Journal of Immunology (Baltimore, Md. : 1950)
|June 15, 1989
Summary
Immobilized alloantigen activates cloned cytotoxic T lymphocytes (CTL) via T cell receptor (TCR) and CD8 interactions. Activation requires a critical antigen density, with coimmobilized class I proteins lowering this threshold.
Area of Science:
- Immunology
- Cellular immunology
- T cell activation
Background:
- Cytotoxic T lymphocytes (CTL) play a crucial role in adaptive immunity.
- Understanding the molecular interactions governing CTL activation is essential for immunotherapy and transplantation.
- Class I major histocompatibility complex (MHC) molecules present antigens to CTL.
Purpose of the Study:
- To investigate the immobilization of class I alloantigens and their ability to activate cloned CTL.
- To determine the role of antigen density and co-stimulatory molecules in CTL activation.
- To compare the ligand requirements for effector CTL activation with those of precursor CTL.
Main Methods:
- Direct immobilization of affinity-purified class I proteins onto plastic surfaces.
- Assessment of T cell receptor (TCR)-mediated degranulation of cloned CTL.
- Analysis of antigen density thresholds and the effect of co-immobilized proteins (class I and class II).
Main Results:
- Immobilized alloantigen retains native structure and triggers specific TCR-mediated degranulation.
- CTL activation is dependent on a critical surface density of alloantigen, with individual clones exhibiting varying thresholds.
- Co-immobilization of non-antigenic class I proteins decreases the alloantigen threshold, mediated by Lyt-2 (CD8) interaction.
Conclusions:
- Class I alloantigen is a necessary and sufficient ligand for activating most allogeneic CTL clones.
- Both TCR and Lyt-2 (CD8) interactions are critical for CTL activation.
- The findings provide insights into the ligand requirements for both effector and precursor CTL activation.